Interfaculty Institute for Cell Biology (IFIZ)

The Interfaculty Institute for Cell Biology (IFIZ) was established at the University of Tübingen in 1997. Its members are active in different fields comprising Biology, Medicine, Chemistry and Pharmacology. Two faculties support the IFIZ: the Faculty of Science and the Faculty of Medicine.

Structure of the Institute

RU = Research Unit
CF = Core Facility

I. Molecular Biology (Prof. Nordheim)

• RU Knöll (Emmy-Noether Research Group Neural Gene Expression)
• RU Nordheim (Molecular Control of Organ Function)
• RU Proikas-Cezanne (Autophagy)

II. Immunology (Prof. Rammensee)

• Hans-Georg Rammensee (Department Head)
• RU Cécile Gouttefangeas (T-Cell Monitoring)
• RU Gundram Jung (Section of Experimantal Antibody Therapy)
• RU Stefan Stevanović (Molecular Immunology)
• RU Oliver Planz (Translational Immunology of Infection)
• RU Ralf Amann (ORFV virus vector vaccines)
• RU Alexander Weber (Innate Immunity)
• RU Juliane Walz (Junior Research Group Leader)
• RU Sebastian Haen (Junior Research Group Leader)

III. Animal Genetics (Prof. Reuter)

• RU Reuter

IV. Quantitative Proteomics (Prof. Macek)

• RU Macek: proteomics in experimental systems biology
• CF Proteome Center Tübingen (PCT): the PCT is a core facility of the University of Tübingen dedicated to the analysis of proteins, protein modifications and of entire proteoms.

V. Molecular Cell Biology

• RU Jennifer Ewald

Entrepreneurial Activities

The Institute has been engaged in the founding of the following biotechnology companies:

• CureVac, Tübingen (Co-founder: Prof. Rammensee)
• Immatics Biotechnolologies, Tübingen (Co-founder: Prof. Rammensee)
• ProteoSys AG, Mainz (Co-founder: Prof. Nordheim)